Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A trial of decitabine and ECF chemotherapy for advanced stomach cancer
This trial was looking at a drug called decitabine in combination with ECF chemotherapy for advanced stomach cancer.
Doctors often treat cancer of the stomach (gastric cancer) with chemotherapy and surgery. One of the most common types of chemotherapy for stomach cancer is a combination of drugs called ECF. This is epirubicin, cisplatin and fluorouracil (5FU).
In this trial, doctors wanted to see if another drug called decitabine made ECF work better. Decitabine works by changing the activity of some of the
The aims of the trial were to find out
- The best dose of decitabine to give
- What the side effects were
- How well decitabine and ECF worked together
Summary of results
Despite attempting to contact the trial team, we have been unable to get any results for this trial.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Mark Middleton
Experimental Cancer Medicine Centre (ECMC)
MGI Pharma Inc